Cardiovascular
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Astellasmirabegron
PfizerAtorvastatin Initiators
Clinical Trials (2)
Total enrollment: 31,651 patients across 2 trials
A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin
Start: Aug 2010Est. completion: Feb 201148 patients
Phase 1Completed
Cardiovascular Events Based On Statin Initiation In The Elderly
Start: Nov 2009Est. completion: Feb 201131,603 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space